Hierarchically weighted principal component analysis method was employed to assess the inhibitory potency of different antifungal azoles to Candida albicans lanosterol-14α-demethylase. Information regarding the molecular properties and biological activity of the antifungal azoles was utilized for evaluation. The molecular weight, complexity, heavy atom count, and rotatable count were identified as the most significant variables describing the inhibitory potency of the antifungal drugs. Newer generation drugs including itraconazole and fluconazole were identified to have better inhibitory potency than bifonazole and clotrimazole. The present study illustrated a method providing an effective approach in classifying antifungal azoles based on molecular properties and biological activity for possible synthesis of newer generation antifungal drugs for a better and more effective treatment of fungal infections.
Introduction
Nearly every part of the gastrointestinal tract, from the oral cavity up to the perianal tissues, epidermis, and the vulvovaginal region, is colonized by Candida albicans (Pfaller & Diekema 2007) . However, C. albicans is notorious for causing candidiasis, with the potential of becoming a systemic infection, subsequently provoking a much more serious medical condition (Rekha & Visyasagar 2013) . There is an increase in the frequency of infections globally due to pathogenic microorganisms resulting to increased cases of morbidity and mortality. Candida albicans is the most common human fungal pathogen, and mortality from C. albicans infection is still unacceptably high (Pfaller & Diekema 2007) . These mycoses are commonly found in medical practice in increasing frequency, mainly because of broad-spectrum antibiotic therapy (Ghannoum & Rice 1999) . In the therapeutic management of systemic fungal infections and local mycoses, azoles remain the currently used antifungal agents (Zonios & Bennett 2008) and have been an important pharmacophore and privileged structure in medicinal chemistry. Azoles inhibit fungal lanosterol-14α-demethylase, an important enzyme in the synthesis of ergosterol, a major fungal plasma membrane component (Zampieri et al. 2007 ). Lanosterol-14α-demethylase or CYP51 (cytochrome P450 isoenzyme 51), a family of phylogenetic highly conserved monooxygenases, was identified in humans, plants, animals, fungi, and mycobacteria (Lepesheva & Waterman 2004) . It is a rate limiting step in the production of follicular fluid-meiosis activating steroid, a precursor in mammalian and yeast sterol biosynthesis (Rozman & Waterman 1998) , which subsequently leads in the synthesis of ergosterol, in the case of fungi. This explains the mechanism of azoles as fungicides inhibiting CYP51 which results in the absence of ergosterol, an essential fungal cell membrane component. However, C. albicans infections detect several problems including relapse of the fungal infections, resistance to commonly used antifungals, and availability of potent and inexpensive effective antifungal agents. Hence, the search for new and effective synthetic inhibitors of C. albicans is an actual and important task for basic science and clinical medicine. In this study, the inhibitory potency of different antifungal azoles to lanosterol-14α-demethylase of C. albicans was assessed using hierarchically weighted principal component analysis method. Molecular descriptors, geometrical properties, and electronic parameters such as molecular weight, rotatable count, complexity, hydrogen bond donor and acceptor counts, topological polar surface area, lipophilicity, heavy atom count, and undefined atom stereocenter were considered as indices in the evaluation of the biological activity (IC50) of currently available antifungal agents. The experimental measurement of bioactivity of compounds is difficult, time-consuming, and expensive. Hence, attempts such as statistical modeling were done to predict these biological activities (Sumalapao et al. 2018 ). The present study illustrated the utility of hierarchically weighted principal component analysis method as an effective approach in classifying antifungal azoles, based on molecular properties and biological activity for possible synthesis of newer generation antifungal drugs for a better and more effective treatment of fungal infections.
Materials & Methods

Biological Activity of Antifungal Azoles
Biological information on the inhibitory potencies (IC50) of the nineteen (19) different antifungal agents, thirteen (13) of which were used in agriculture and six (6) in human medicine, on C. albicans CYP51 was obtained from literature (Trosken et al. 2006) . The thirteen fungicides used agriculturally were bitertanol, cyproconazole, epoxiconazole, flusilazole, hexaconazole, imazalil, myclobutanil, penconazole, prochloraz, propiconazole, tebuconazole, triadimefon, and triadimenol. Bifonazole, clotrimazole, fluconazole, itraconazole, ketoconazole, and miconazole were the six human medicine antimycotics.
Structural and Molecular Properties of Antifungal Azoles
Molecular descriptors, geometrical properties, and electronic parameters of the azoles evaluated in this study include molecular weight, rotatable count, complexity, hydrogen bond donor and acceptor counts, topological polar surface area, lipophilicity, heavy atom count, and undefined atom stereocenter. Information regarding these descriptors of the nineteen antifungal azoles (Table  1) was obtained from the National Center for Biotechnology Information (NCBI) databases.
Principal component analysis
In this study, principal component analysis was employed primarily to describe the similarity among antifungal agents and the correlations among the molecular descriptors. This multivariate statistical approach summarizes and visualizes information present in the data set including a small number of new variables (principal components) which are uncorrelated linear combinations with maximal variance (Lebart et al. 1984 , Jolliffe 2002 , Hastie et al. 2009 ). In this method, a given set of correlation variables is transformed into another set of uncorrelated variables by linear transformation, and subsequently these new variables are arranged in order of decreasing variance. The total variance of the variables is kept constant, such that the first principal component assumes the largest variance, with subsequent components in decreasing variance not related to the previous 46 principal components. In this study, all statistical analyses were carried out using STATA © at 5% level of significance. 2018a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s Results Descriptive measures of the nineteen different antifungal agents tested for their inhibitory potencies on C. albicans CYP51 and their respective molecular properties (molecular weight, rotatable count, complexity, hydrogen bond donor and acceptor counts, topological polar surface area, lipophilicity, heavy atom count, and undefined atom stereocenter) as indices of biological activity evaluation were calculated ( Table 2 ). The range of inhibitory potency is from 0.039 to 0.350 μM among the identified antifungal drugs on CYP51 of C. albicans. (Trosken et al. 2006) Loading values of each evaluation index in the principal components were calculated using STATA © at 5% level of significance. Based on principal component contribution rate, the first, second, and third principal components accounted for 51.79%, 25.50%, and 11.38%, respectively (Table 3 ). The indices identified in the first principal component are the molecular weight, rotatable 47 count, complexity, and heavy atom count. These indices in the first principal component describe the molecular complexity of the antifungal agents. Moreover, the indices included in the second principal component are the hydrogen bond donor count, topological polar surface area, and lipophilicity. The third principal component included lipophilicity and undefined atom stereocenter. Therefore, the biological activity of the antifungal agents was mainly influenced by the first and second principal components consisting of molecular weight, rotatable count, complexity, and heavy atom count, followed by hydrogen bond donor count, topological polar surface area, and lipophilicity. When hierarchically weighted principal component analysis method was employed in evaluating the inhibitory potency of the different antifungal azoles, resulting calculated comprehensive scores ranged from 2.38 to 6.43 (Table 4) , with higher comprehensive scores identified in the newer generations of antifungal agents compared with the older generations. Moreover, comprehensive scores for antifungal agents intended as human medicines for mycoses are at least 4.00 for newer generation agents and at most 3.00 for the older antifungal drugs, while azoles for agricultural purposes have comprehensive scores ranging between 3.00 to 4.00 (Table 4) . (Trosken et al. 2006) Among the molecular properties of antifungal azoles evaluated in this study, molecular weight has been identified to have a positive correlation with the complexity, rotatable count, heavy atom and hydrogen bond acceptor counts (Table 5 ). In the correlation analysis, topological polar surface area is directly correlated with hydrogen bond acceptor and rotatable counts (Table 5) . Lipophilicity of the antifungal azoles was positively correlated with molecular weight and heavy atom count but negatively correlated with hydrogen bond donor count (Table 5) . On the other hand, molecular complexity is directly correlated with hydrogen bond acceptor count and rotatable count (Table 5) . 
Discussion
When principal component analysis method was employed, the present study identified itraconazole as the most potent among the antifungal azoles. This is in complete agreement with the findings of Trosken et al. (2006) . Among the molecular properties of antifungal azoles evaluated in this study, molecular weight has been identified to have a positive correlation with the complexity, rotatable count, heavy atom and hydrogen bond acceptor counts. In small molecule drug discovery, molecular weight is an important property (Meanwell 2011 , Leeson 2016 ) commonly monitored during the compound optimization steps, as this can influence several molecular events including absorption, interactions with on-and off-targets, blood brain barrier penetration, and bile elimination rate (Gleeson 2008) . On the other hand, molecular complexity is directly correlated with hydrogen bond acceptor count and rotatable count. Molecular complexity accounts the fraction of sp 3 -hybridized carbons, the number of stereocenters, and the number of rings and aromatic rings. Aromaticity increases log p and affinity for albumin, but it decreases the free unbound form species of the molecule and its aqueous solubility (Ritchie & Macdonald 2009 ). Moreover, a molecule with more than three aromatic rings was associated with increased risk of toxicity (herg and cyp inhibition) and had poorer compound developability (Lovering et al. 2009 ). Complexity indices based on the first-order topological neighborhood of atoms (Roy et al. 1984) considered the number of hydrogen atoms and the presence of double and triple bonds (Hendrickson et al. 1987) . Because of specific binding events in the complete ligand molecule, moderately complex structures were preferred lead compounds (Hann et al. 2001 ). Molecular complexity is related with biological activity (Hann & Oprea 2004 ) and molecular pharmacologic properties including solubility, oral bioavailability, permeability, promiscuity, and clinical progression (Lovering 2013) .
In the present study, hydrogen bond donor count was one of the primary indices included in the second principal component. Hydrogen bond donors and acceptors were identified to be related with the polarity and permeability of compounds (Alex et al. 2011) . Hydrogen bond donor count corresponds to the total number of hydrogen atoms bonded to any oxygen and nitrogen atoms without negative charge in the molecule, while hydrogen bond acceptor count sums up any oxygen, fluorine, and nitrogen atoms excluding pyrrolyl nitrogen form, higher oxidation states, and positive formal charge. Among the marketed oral drugs, molecular weight and hydrogen bond acceptor have significantly increased, whereas lipophilicity and hydrogen bond donor have shown relatively limited changes over time (Wenlock et al. 2003 , Leeson & Davis 2004 , suggesting that hydrogen bond donor count may be more important than hydrogen bond acceptor count (Baell et al. 2013 , Leeson 2016 as 49 hydrogen bond donor count enhanced bioavailability and membrane permeability (Leeson & Davis 2004) .
Moreover, lipophilicity of the antifungal azoles was positively correlated with molecular weight and heavy atom count but negatively correlated with hydrogen bond donor count. This index, an important determinant in optimizing the pharmacodynamic and pharmacokinetic properties of molecules in medicinal chemistry and in computer-aided drug design (Kujawski et al. 2012) , influences molecular permeability, absorption, bioavailability, metabolism, toxicity, distribution, potency, and excretion parameters. Metabolism and solubility are more likely compromised by high lipophilic compounds, whereas low lipophilicity decreases permeability (Waring 2010) . Highly lipophilic compounds resulted in promiscuity and toxicity problems such as cytochrome p450 and herg inhibitions (Gleeson 2008 , Waring 2010 . Lipophilicity governs the kinetics and dynamics of drug action since optimal lipophilicity range, along with low polar surface area and molecular weight, results in better intestinal absorption of the drug via passive diffusion (Kubinyi 1979 , Dearden 1985 .
In the correlation analysis, topological polar surface area is directly correlated with hydrogen bond acceptor and rotatable counts. Topological polar surface area, an important parameter in predicting drug transport properties, correlates well with Caco-2 monolayers permeability, human intestinal absorption, and blood-brain barrier penetration (Ertl et al. 2000) , oral bioavailability and permeability estimation (Leeson 2016) . When combined with rotatable bond count, topological polar surface area reflects molecular flexibility. Increase in the number of rotatable bonds and topological polar surface area decreases the bioavailability of a compound (Veber et al. 2002) .
In conclusion, inhibitory potency of different antifungal azoles to lanosterol-14α-demethylase of Candida albicans was assessed using hierarchically weighted principal component analysis method. Molecular weight, complexity, heavy atom count, and rotatable count were identified as the most significant molecular properties describing the inhibitory potency of these antifungal drugs. The present study illustrated a method providing an effective approach in classifying antifungal drugs based on molecular properties and biological activity for possible synthesis of newer generation antifungal drugs for a better and more effective treatment of fungal infections.
